DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 81.30.
Share Price | ₹5,622.3 | Feb 01,2025 |
Market Cap | ₹149,272.1 Cr | |
Earnings-TTM | ₹1,836.0 Cr | TTM-Consolidated Results |
Price/Earnings | 81.30x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹149,272.1 Cr] as on Feb 01,2025
(/) Earnings [ ₹1,836.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 81.30x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 81.30 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 44.87x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 41.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2024 at 56.92x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 38.33x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 1,836.00 | 81.30 | 149,272.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.40 | 418,132.0 |
CIPLA LTD | 5,000.43 | 23.22 | 116,123.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.53 | 100,573.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.79 | 97,966.9 |
MANKIND PHARMA LTD | 2,050.73 | 49.91 | 102,348.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.26 | 108,477.0 |
LUPIN LTD | 2,651.94 | 35.38 | 93,813.7 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.45 | 66,385.6 |
ABBOTT INDIA LTD | 1,284.66 | 42.86 | 55,059.0 |
ALKEM LABORATORIES LTD | 2,160.96 | 27.80 | 60,079.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.45x |
Max industry PE | 81.30x |
Median industry PE | 35.38x |
Average industry PE | 37.72x |
You may also like the below Video Courses